CEFTIZOXIME SODIUM - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for ceftizoxime sodium and what is the scope of freedom to operate?
Ceftizoxime sodium
is the generic ingredient in three branded drugs marketed by Astellas and is included in three NDAs. Additional information is available in the individual branded drug profile pages.There are four drug master file entries for ceftizoxime sodium.
Summary for CEFTIZOXIME SODIUM
US Patents: | 0 |
Tradenames: | 3 |
Applicants: | 1 |
NDAs: | 3 |
Drug Master File Entries: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 65 |
Clinical Trials: | 2 |
Patent Applications: | 2,092 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CEFTIZOXIME SODIUM at DailyMed |
Recent Clinical Trials for CEFTIZOXIME SODIUM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Alphacait, LLC | Phase 2 |
Haining Health-Coming Biotech Co., Ltd. | Phase 2 |
Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
Medical Subject Heading (MeSH) Categories for CEFTIZOXIME SODIUM
US Patents and Regulatory Information for CEFTIZOXIME SODIUM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astellas | CEFIZOX | ceftizoxime sodium | INJECTABLE;INJECTION | 050560-003 | Sep 15, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Astellas | CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER | ceftizoxime sodium | INJECTABLE;INJECTION | 050589-002 | Oct 3, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Astellas | CEFIZOX | ceftizoxime sodium | INJECTABLE;INJECTION | 063294-003 | Mar 31, 1994 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |